21 May 2009
Cause of death of the multi-organ donors in relation to the kidney garft function
M Zukowski, R Bohatyrewicz, J Biernawska, K Kotfis, M Zegan, M Janeczek, M OstrowskiAnn Transplant 2009; 14(1): 48-48 :: ID: 880375
Abstract
Background: Brain death is an important multi-factorial variable contributing to donor-specific kidney damage. Aim: Assessment of the influence of the cause of death of the multi-organ donors on the function of transplanted kidneys.
Material/Methods: 146 potential heart donors were included in the study. Brain stem death (BSD) protocol was used according to the standard criteria for the brain death diagnosis. Conventional supportive management consisted of: mechanical ventilation to normocapnia, re-warming, fluid and electrolyte replacement. Kidney recipients (a group of 232 patients) had kidney function monitored by serial serum creatinine level measurements on day 1, 2, 3, 7, 14, 30 and 90 post transplantation. The relationship between donor's cause of death (injury, bleeding and other) and serum creatinine levels in the postoperative period were analyzed. In statistical analysis the following tests were used: U Mann-Whitney, Chi correlation and regression and Fisher tests. A value of p<0.05 indicated statistical significance.
Results: In the group of recipients who received a kidney from donors that died due to reasons other than injury, significantly higher serum creatinine levels were observed up to the 14[sup]th[/sup] day post transplantation. In the group of recipients who received a kidney from donors who died due to bleeding, significantly higher serum creatinine levels were observed since the 30th day post transplantation.
Conclusions: 1. Cause of death other than injury or bleeding in multi-organ donors predicts worse kidney graft function in the first 14 days post transplantation. 2. Intracranial bleeding in multi-organ donors predicts worse kidney graft function in the first period after transplantation.
Keywords: Organ Procurement
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






